Document is current
Any future updates will be listed below
-
Authors
Yang, Luojia
Renauer, Paul A.
Tang, Kaiyuan https://orcid.org/0009-0006-4538-6519
Saskin, Josh https://orcid.org/0000-0001-5372-9696
Zhou, Liqun https://orcid.org/0000-0002-3561-7495
Zou, Charles
Lee, Seok-Hoon
Fox, Madison
Johnson-Noya, Samuel
Weiss, Benedict https://orcid.org/0009-0008-6165-2391
Deng, Stephanie
Fang, Paris
Chen, Binfan
Sferruzza, Giacomo
Fooladi, Saba
Zhao, Kai
Park, Daniel https://orcid.org/0009-0002-6862-6635
Zhang, Feifei
Tu, Jiayi
Chen, Jing https://orcid.org/0000-0002-5376-9062
Moliterno, Jennifer
Gunel, Murat https://orcid.org/0000-0002-2290-7055
Peng, Lei https://orcid.org/0000-0001-7159-5441
Chen, Sidi https://orcid.org/0000-0002-3819-5005
- License Information
-
More Information
Article History
Received: 27 April 2025
Accepted: 15 January 2026
First Online: 25 February 2026
Competing interests
: A patent application has been filed by Yale University and Cellinfinity Bio related to the data in this study (US patent application no. 63/624,561; PCT WO2025158400A1). S.C. is a (co)founder of EvolveImmune Tx, Cellinfinity Bio, MagicTime Med and Chen Consulting. The other authors declare no competing interest.
